Table 1.

Clinical characteristics of the subjects used in the study. ASIA, American Spinal Injury Association; M/F, male/female; NA, not applicable.

		Non COVID	COVID	p-Value
Age (years)		52.7 ± 17.1	61.1 ± 14.4	0.22
Gender (%M/F)		72/28	73/27	0.86
ASIA Impairment scale (%)	A	54	45	NA
	B	8	9	NA
	C	23	9	NA
	D	15	18	NA
Heparin (%)		46	82	0.15
Heparin dose (mg/day)		40	98	0.03